Rankings
▼
Calendar
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$57,000
Gross Profit
$56,000
98.2% margin
Operating Income
-$5M
-8503.5% margin
Net Income
-$4M
-7486.0% margin
EPS (Diluted)
$-0.13
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$329,000
Balance Sheet
Total Assets
$28M
Total Liabilities
$12M
Stockholders' Equity
$16M
Cash & Equivalents
$3M
← FY 2016
All Quarters
Q2 2016 →
AUPH Q1 2016 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
